Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063242) titled 'Benefits and risks of adding immune-modifying medicines to steroid treatment for IgG4-related disease: a review of clinical trials' on Oct. 11.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - IgG4-related disease (IgG4-RD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To synthesize randomized trials comparing immunomodulatory therapies added to glucocorticoid-based treatment with corresponding glucocorticoid-based treatment alone or placebo with the same taper in IgG4-related disease. Efficacy, sa...